
Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.
Liquid biopsies are becoming essential in the lung cancer arena.
Patients undergoing a liquid biopsy will first have their blood and platelets drawn. Then, the DNA will be isolated, and expression panels will be run to see if the person has certain cancer markers. The process is currently one of the most highly specific technologies available in the lung cancer space.






